The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity
- PMID: 16894103
- DOI: 10.1212/01.wnl.0000228242.53336.90
The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity
Abstract
Objective: To develop and evaluate a clinical Spastic Paraplegia Rating Scale (SPRS) to measure disease severity and progression.
Methods: A 13-item scale was designed to rate functional impairment occurring in pure forms of spastic paraplegia (SP). Additional symptoms constituting a complicated form of SP are recorded in an inventory. Two independent patient cohorts were evaluated in a two-step validation procedure.
Results: Application of SPRS requires less than 15 minutes and does not require any special equipment, so it is suitable for an outpatient setting. Interrater agreement of SPRS was high (intraclass correlation coefficient = 0.99). Reliability was further supported by high internal consistency (Cronbach alpha = 0.91). SPRS values were almost normally distributed without apparent floor or ceiling effect. Construct validity was shown by high correlation of SPRS to Barthel Index and the International Cooperative Ataxia Rating Scale (convergent validity) and low correlation to Mini-Mental Status Examination (discriminant validity).
Conclusion: The Spastic Paraplegia Rating Scale is a reliable and valid measure of disease severity.
Similar articles
-
Development and validation of a muscular dystrophy-specific functional rating scale.Clin Rehabil. 2006 Sep;20(9):804-17. doi: 10.1177/0269215506070809. Clin Rehabil. 2006. PMID: 17005504
-
Scale for the assessment and rating of ataxia: development of a new clinical scale.Neurology. 2006 Jun 13;66(11):1717-20. doi: 10.1212/01.wnl.0000219042.60538.92. Neurology. 2006. PMID: 16769946 Clinical Trial.
-
Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment.Brain. 2008 May;131(Pt 5):1352-61. doi: 10.1093/brain/awn059. Epub 2008 Mar 31. Brain. 2008. PMID: 18378516
-
Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome.Sleep Med. 2007 Aug;8(5):455-63. doi: 10.1016/j.sleep.2007.03.023. Epub 2007 May 31. Sleep Med. 2007. PMID: 17543579 Clinical Trial.
-
Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients.Mov Disord. 2006 May;21(5):699-704. doi: 10.1002/mds.20781. Mov Disord. 2006. PMID: 16450347
Cited by
-
Dalfampridine in hereditary spastic paraplegia: a prospective, open study.J Neurol. 2015 May;262(5):1285-8. doi: 10.1007/s00415-015-7707-6. Epub 2015 Mar 26. J Neurol. 2015. PMID: 25808501
-
Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4.Ann Clin Transl Neurol. 2022 Mar;9(3):326-338. doi: 10.1002/acn3.51518. Epub 2022 Feb 16. Ann Clin Transl Neurol. 2022. PMID: 35171517 Free PMC article.
-
Nerve ultrasound characterizes AMN polyneuropathy as inhomogeneous and focal hypertrophic.Orphanet J Rare Dis. 2018 Nov 3;13(1):194. doi: 10.1186/s13023-018-0939-7. Orphanet J Rare Dis. 2018. PMID: 30390710 Free PMC article.
-
Hand muscles corticomotor excitability in hereditary spastic paraparesis type 4.Neurol Sci. 2014 Aug;35(8):1287-91. doi: 10.1007/s10072-014-1707-7. Epub 2014 Mar 20. Neurol Sci. 2014. PMID: 24648003
-
Novel SPAST deletion and reduced DPY30 expression in a Spastic Paraplegia type 4 kindred.BMC Med Genet. 2014 Apr 1;15:39. doi: 10.1186/1471-2350-15-39. BMC Med Genet. 2014. PMID: 24690193 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
